← Back to Search

Procedure

Focused Ultrasound for Low Grade Glioma

N/A
Waitlist Available
Led By Sheldon Jordan, M.D.
Research Sponsored by Neurological Associates of West Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 or older
Be older than 18 years old
Must not have
Cognitive decline with mild cognitive impairment (Clinical Dementia Rating stage 0.5) through moderate dementia CDR stages 1 and 2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Summary

This trial is testing whether focused ultrasound can be used to treat brain pathologies in a less invasive way than current methods.

Who is the study for?
This trial is for adults over 18 with low grade gliomas who are already getting regular MRI scans. It's not for those with cognitive decline from mild to moderate dementia.
What is being tested?
The study tests the use of focused ultrasound on the brain. The goal is to see if it can safely make the blood-brain barrier more permeable, potentially helping treat brain conditions less invasively.
What are the potential side effects?
Since this is a non-invasive technique, side effects may be minimal but could include discomfort at the site of ultrasound application or temporary headache.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have mild to moderate memory or thinking problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adverse Event (AE) & Serious Adverse Event (SAE) Reporting
functional Magnetic Resonance Imaging (fMRI)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Focused UltrasoundExperimental Treatment1 Intervention
The ultrasound treatment will last either 1 hour or 20 minutes total time for the DWL device or Brainsonix Focused Ultrasound Device, respectively.

Find a Location

Who is running the clinical trial?

Neurological Associates of West Los AngelesLead Sponsor
25 Previous Clinical Trials
3,945 Total Patients Enrolled
Sheldon Jordan, M.D.Principal InvestigatorNeurologist, NAOWLA
4 Previous Clinical Trials
900 Total Patients Enrolled

Media Library

Low Grade Glioma Research Study Groups: Focused Ultrasound
Low Grade Glioma Clinical Trial 2023: Focused Ultrasound Highlights & Side Effects. Trial Name: NCT04063514 — N/A
Focused Ultrasound (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04063514 — N/A
~5 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top